Better FDA-NIH Cooperation Urged To Ease Barriers To Introducing Products
This article was originally published in The Tan Sheet
Executive Summary
FDA and National Institutes of Health staff should compare notes earlier to ensure research conducted under the NIH umbrella also meets the needs of FDA regulators, according to comments at a public meeting sponsored by the agencies